BPC-157 Studied Torn Rotator Cuff: Comparison Table
Before considering any intervention for rotator cuff injury, understanding how BPC-157 compares to standard treatments and other emerging therapies is essential. The table below contrasts mechanism, evidence quality, typical timelines, and clinical availabilit
This comparison does not assign a generated winner or score.
- Before considering any intervention for rotator cuff injury, understanding how BPC-157 compares to standard treatments and other emerging therapies is essential. The table below contrasts mechanism, evidence quality, typical timelines, and clinical availability.
- BPC-157
- Stimulates fibroblast proliferation, angiogenesis, collagen synthesis via FAK-paxillin and VEGF pathways
- Animal studies only. No Phase 3 human trials
- Unknown in humans; animal models show 30–50% faster healing at 14–28 days
- Research-grade peptide suppliers; not FDA-approved for human use
- Mechanistically promising but unproven in human rotator cuff injuries. All current claims extrapolate from rat tendon models
- Surgical Repair
- Mechanical reattachment of torn tendon to bone using suture anchors
- Gold standard for full-thickness tears; large body of clinical outcome data
- 4–6 months to functional recovery; 9–12 months for full strength
- Widely available via orthopedic surgeons
- Still the definitive treatment for complete tears. Success rate 70–90% depending on tear size and tissue quality
- PRP Injections
- Platelet-derived growth factors promote collagen synthesis and reduce inflammation
- Mixed evidence; some trials show benefit, others no difference vs placebo
- 6–12 weeks for symptom improvement; does not repair complete tears
- Available through sports medicine and regenerative clinics
- May augment healing in partial tears or post-surgery. Should not replace surgical repair for full-thickness tears
- Physical Therapy
- Strengthens surrounding musculature, restores range of motion, reduces compensatory strain
- Strong evidence for partial tears and non-operative management
- 8–16 weeks for symptom reduction in partial tears
- Widely available
- First-line treatment for partial tears and post-surgical recovery. Cannot heal complete tears but prevents re-injury